These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 18463539)
1. Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells. Capobianco A; Manfredi AA; Monno A; Rovere-Querini P; Rugarli C J Immunother; 2008 Jun; 31(5):458-65. PubMed ID: 18463539 [TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma. Lee TH; Cho YH; Lee JD; Yang WI; Shin JL; Lee MG Immunol Lett; 2006 Jul; 106(1):19-26. PubMed ID: 16647143 [TBL] [Abstract][Full Text] [Related]
3. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Hu J; Yuan X; Belladonna ML; Ong JM; Wachsmann-Hogiu S; Farkas DL; Black KL; Yu JS Cancer Res; 2006 Sep; 66(17):8887-96. PubMed ID: 16951206 [TBL] [Abstract][Full Text] [Related]
9. The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells. Fujisawa Y; Nabekura T; Nakao T; Nakamura Y; Takahashi T; Kawachi Y; Otsuka F; Onodera M Exp Dermatol; 2009 Apr; 18(4):396-403. PubMed ID: 19054057 [TBL] [Abstract][Full Text] [Related]
10. Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells. Capobianco A; Rovere-Querini P; Rugarli C; Manfredi AA Int J Cancer; 2006 Dec; 119(12):2861-9. PubMed ID: 16998790 [TBL] [Abstract][Full Text] [Related]
11. DC therapy induces long-term NK reactivity to tumors via host DC. Shimizu K; Fujii S Eur J Immunol; 2009 Feb; 39(2):457-68. PubMed ID: 19180466 [TBL] [Abstract][Full Text] [Related]
12. Helper role of NK cells during the induction of anticancer responses by dendritic cells. Kalinski P; Giermasz A; Nakamura Y; Basse P; Storkus WJ; Kirkwood JM; Mailliard RB Mol Immunol; 2005 Feb; 42(4):535-9. PubMed ID: 15607810 [TBL] [Abstract][Full Text] [Related]
13. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies. Fujii S Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215 [TBL] [Abstract][Full Text] [Related]
14. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells]. Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759 [TBL] [Abstract][Full Text] [Related]
15. Increased survival and decreased tumor size due to intratumoral injection of ethanol followed by administration of immature dendritic cells. Kumagi T; Akbar SM; Horiike N; Onji M Int J Oncol; 2003 Oct; 23(4):949-55. PubMed ID: 12963973 [TBL] [Abstract][Full Text] [Related]
16. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus. Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206 [TBL] [Abstract][Full Text] [Related]
17. Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells. Cui F; Ji J; Lv H; Qu D; Yu C; Yang Y; Xu Y J Cancer Res Ther; 2013 Nov; 9 Suppl():S162-8. PubMed ID: 24516054 [TBL] [Abstract][Full Text] [Related]
18. The 'kiss of death' by dendritic cells to cancer cells. Chan CW; Housseau F Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029 [TBL] [Abstract][Full Text] [Related]
19. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously. Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973 [TBL] [Abstract][Full Text] [Related]